welcomes you to the new, improved website!
Drs Patrick Myers, David Taggart, and Michael Mack discuss the ORBITA trial, focusing on the importance of the sham-control design of the trial, ORBITA’s context within previous and upcoming trials, and what the results mean for cardiac surgeons.
You are here:
Podcast Episode: The ORBITA Trial Results: What Do They Mean for Surgeons?
By: Patrick Myers
, ,
Keywords:
- Back to Legacy Podcast
More of Legacy Podcast
In this CTSNet To Go podcast, we share the archived version of the webinar that concluded ...
In this CTSNet To Go podcast, Joel Dunnng interviews Isabelle Opitz of University Hospital Zurich, Switzerland. ...
In this CTSNet To Go podcast, the Leadership Book Club, hosted by Ara Vaporciyan, program manager ...
In this CTSNet To Go podcast episode, Jessica Luc of the University of British Columbia in ...
In this CTSNet To Go podcast episode, Lisa R. DeGarmo of McGovern Medical School at UTHealth ...
In this CTSNet To Go podcast episode, Mara Antonoff of the University of Texas MD Anderson ...
In this Giants of Cardiothoracic Surgery interview, Joel Dunning speaks with Oscar Howard “Bud” Frazier about ...
In this CTSNet To Go podcast episode, Jessica G. Y. Luc of the University of British ...
In this CTSNet To Go episode, Edward M. Bender of Stanford University in California, USA, moderates ...
In this CTSNet To Go podcast episode, Niv Ad moderates a discussion on the importance of ...
In this CTSNet To Go podcast episode, Mara Antonoff moderates a roundtable on the role of ...
In this CTSNet To Go episode, David Tom Cooke moderates a discussion on innovative curriculum design ...
David Jablons moderated this live event, originally recorded on Nov. 18, 2020, which presented data about ...
In this CTSNet To Go podcast episode, Guest Editor Konstadinos A. Plestis and his panelists discuss ...
In this Giants of Cardiothoracic Surgery interview, Jessica Luc speaks with Lars G. Svensson of the ...
